BeOne Medicines (ONC) Retained Earnings (2015 - 2026)
BeOne Medicines (ONC) reported Retained Earnings of -$8.1 billion for Q1 2026, down 5586.12% year-over-year from $147.5 million in Q1 2025, and up 2.73% on a QoQ basis from -$8.3 billion in Q4 2025.
BeOne Medicines (ONC) has 12 years of Retained Earnings data on file, last reported at -$8.1 billion in Q1 2026.
- Quarterly Retained Earnings fell 5586.12% year-over-year to -$8.1 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$8.1 billion (down 5586.12% YoY) and the FY2025 annual result came in at -$8.3 billion, up 3.33% from the prior year.
- Retained Earnings climbed to -$8.1 billion in Q1 2026 per ONC's latest filing, from -$8.3 billion in the prior quarter.
- Across five years, Retained Earnings topped out at $17.5 million in Q1 2022 and bottomed at -$8.6 billion in Q4 2024.
- The 5-year median for Retained Earnings is -$161.5 million (2022), against an average of -$3.8 billion.
- The widest annual swing landed in 2022, when Retained Earnings jumped 444.76%; it then plunged 42662.01% in 2023.
- Tracing ONC's Retained Earnings over 5 years: stood at -$77.4 million in 2022, then dropped by 28.45% to -$99.4 million in 2023, then sank by 8554.78% to -$8.6 billion in 2024, then climbed by 3.33% to -$8.3 billion in 2025, then increased by 2.73% to -$8.1 billion in 2026.
- Per Business Quant, the three latest ONC Retained Earnings figures stand at -$8.1 billion (Q1 2026), -$8.3 billion (Q4 2025), and -$101.3 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | -211.85 Mn |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | -153.89 Mn |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 1.00 Bn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | -438.66 Mn |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | -279.00 Mn |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 14.59 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 36.42 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | 130.89 Mn |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | -24.89 Mn |
| 10 | BeOne Medicines | - | - | 1.35 Bn | -8.09 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -8.09 Bn |
| Dec 31, 2025 | -8.32 Bn |
| Sep 30, 2025 | -101.26 Mn |
| Jun 30, 2025 | -113.70 Mn |
| Mar 31, 2025 | -142.32 Mn |
| Dec 31, 2024 | -8.61 Bn |
| Sep 30, 2024 | -8.45 Bn |
| Jun 30, 2024 | -140.47 Mn |
| Mar 31, 2024 | -8.21 Bn |
| Dec 31, 2023 | -99.45 Mn |
| Sep 30, 2023 | -7.59 Bn |
| Jun 30, 2023 | -7.81 Bn |
| Mar 31, 2023 | -7.43 Bn |
| Dec 31, 2022 | -77.42 Mn |
| Sep 30, 2022 | -161.52 Mn |
| Jun 30, 2022 | -82.45 Mn |
| Mar 31, 2022 | 17.45 Mn |
| Dec 31, 2021 | 17.95 Mn |
| Sep 30, 2021 | 12.58 Mn |
| Jun 30, 2021 | -3.97 Bn |
| Mar 31, 2021 | 3.20 Mn |
| Dec 31, 2020 | 6.94 Mn |
| Sep 30, 2020 | -3.08 Bn |
| Jun 30, 2020 | -9.30 Mn |
| Mar 31, 2020 | -6.55 Mn |
| Dec 31, 2019 | -1.96 Bn |
| Sep 30, 2019 | -14.83 Mn |
| Jun 30, 2019 | -225,000.00 |
| Mar 31, 2019 | 6.07 Mn |
| Dec 31, 2018 | 1.53 Mn |
| Sep 30, 2018 | -738.96 Mn |
| Jun 30, 2018 | -594.93 Mn |
| Mar 31, 2018 | 320,000.00 |
| Dec 31, 2017 | -480,000.00 |
| Sep 30, 2017 | -231.19 Mn |
| Jun 30, 2017 | -348.58 Mn |
| Mar 31, 2017 | -288.04 Mn |
| Dec 31, 2016 | -946,000.00 |
| Sep 30, 2016 | -965,000.00 |
| Jun 30, 2016 | -1.46 Mn |
| Mar 31, 2016 | -1.25 Mn |
| Dec 31, 2015 | -1.81 Mn |